{
    "title": "U.S. FDA extends review period for expanded use of Abbvie's psoriasis drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10562227/U-S-FDA-extends-review-period-expanded-use-Abbvies-psoriasis-drug.html",
    "date": "2022-02-28",
    "keywords": [
        "drug",
        "skyrizi",
        "use",
        "psoriasis",
        "disease",
        "inc",
        "monday",
        "health",
        "agency",
        "review",
        "period",
        "need",
        "time",
        "company",
        "food",
        "administration",
        "application",
        "age",
        "type",
        "bowel",
        "companys",
        "quarter",
        "part",
        "collaboration",
        "boehringer",
        "ingelheim",
        "abbvie",
        "development",
        "commercialization",
        "reporting",
        "roy",
        "bengaluru",
        "editing",
        "daniel"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}